Xilio Therapeutics share price logo

Xilio Therapeutics

NASDAQ: XLO

$9.46

+0.29

(+3.16%)

as on

Xilio Therapeutics Stock Performance

as on August 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $9.07
    $9.75
    downward going graph

    4.12%

    Downside

    3.07%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.47
    $12.74
    downward going graph

    31.66%

    Downside

    34.66%

    Upside

    downward going graph

Xilio Therapeutics share price movements today

Previous Close
$9.17
Open
$9.30
Volume
194.9K
Market Cap
$60.3M
Day's Low - High
$9.07 - $9.75
52 Week Low - High
$6.47 - $12.74

Xilio Therapeutics Historical Returns

1 Month Return
+ 3.27 %
3 Month Return
+ 9.69 %
1 Year Return
-7.62 %
3 Year Return
-75.65 %
5 Year Return
0 %

Xilio Therapeutics Stock Fundamentals & Key Indicators

Check Xilio Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$60.3M

EPS (TTM)

-1.49

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-6.05

Industry PE ratio

-1.5966015625

PEG Ratio

-0.02671194130780983

EBITDA

-20.5M

Revenue (TTM)

64.1M

Profit Margin

99.46%

Return On Equity TTM

-50.77%

Xilio Therapeutics Stock Valuation

Track how Xilio Therapeutics P/E has moved over time to understand its valuation trends.

Xilio Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-5.77x)

December 31, 2021

Today (-2.14x)

December 31, 2025

Industry (-1.60x)

December 31, 2025

Highest (-0.20x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -2.14x

Xilio Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Xilio Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$60.3MNA-6.0599.46%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Xilio Therapeutics Stock including INR - Dollar returns

The Xilio Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Xilio Therapeutics investment value today

Current value as on today

₹1,04,344

Returns

₹4,344

(+4.34%)

Returns from Xilio Therapeutics Stock

-₹4,695 (-4.69%)

Dollar Impact

₹9,039 (+9.04%)

Analyst Recommendation on Xilio Therapeutics Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Xilio Therapeutics. Average target price of $20

Xilio Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Xilio Therapeutics.

What analysts predicted

52.7%UPSIDE

Target Price

$20

Current Price

$9.46

Analyzed by

7 Analysts

Target

$20.00

Xilio Therapeutics target price $20, a slight upside of 52.7% compared to current price of $9.46. According to 7 analysts rating.

Indian Investors' Interest in Xilio Therapeutics Stock

Search interest for Xilio Therapeutics Stock has increased by 25% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:25% versus previous 30 day period

Xilio Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
2
2
1
2
8
19
13
12
18
Gross Profit
-
2
2
1
2
-7
19
13
12
18
Operating Income
-17
-14
-14
-13
-13
-14
-1
-11
-14
-3
EBITDA
-16
-14
-14
-12
-12
-15
-15
10
-9
-6
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-17
-13
-14
-13
-13
-15
-16
10
-9
-6
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-17
-13
-14
-13
-13
-15
-16
10
-9
-6
Net Profit Margin
0.00%
100.00%
100.00%
100.00%
100.00%
-89.63%
100.00%
100.00%
97.28%
100.00%

Xilio Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
6
43
Gross Profit
0
-1
-1
-
-
6
42
Operating Income
-19
-54
-75
-89
-79
-60
-41
EBITDA
-17
-53
-73
-86
-74
-58
-33
Interest Expense
-
0
0
-
-
0
-
Depreciation
0
1
1
1
1
1
1
Income Before Tax
-17
-55
-75
-88
-76
-58
-35
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-17
-55
-75
-88
-76
-58
-35
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%
96.48%

Xilio Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-17
-13
-14
-13
-13
-15
-16
10
-9
-6
Operating Cash Flow
-10
19
-13
-14
28
-14
-17
-1
-22
-18
Investing Cash Flow
-
0
0
0
0
0
-
0
0
0
Financing Cash Flow
0
20
0
8
4
47
0
35
35
4
Change in Cash
-9
39
-13
-5
33
32
-17
33
12
-12

Xilio Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-17
-55
-75
-88
-76
-58
-35
Operating Cash Flow
-17
-36
-80
-75
-68
-18
-4
Investing Cash Flow
0
-2
-1
-1
0
0
0
Financing Cash Flow
60
10
260
0
-6
29
87
Change in Cash
41
-28
178
-77
-75
10
82

Mutual Funds that own Xilio Therapeutics Stock

Check out the Mutual Funds with significant holdings in Xilio Therapeutics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
1.682169%
110605
VANGUARD INSTITUTIONAL INDEX FUNDS
0.19855%
13055
Victory Portfolios III
0.016836%
1107

Global Institutional Holdings in Xilio Therapeutics

Funds
Holdings
Vanguard
2.71%
iShares
0.13%
Dimensional
0.02%

Insights on Xilio Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 595.5% return, outperforming this stock by 671.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 460.9% return, outperforming this stock by 468.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, XLO stock has moved down by -75.7%

About Xilio Therapeutics

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of masked immuno-oncology therapies. The company's pipeline includes XTX501, a bispecific PD-1 / masked IL-2, for patients with metastatic non-small cell lung cancer; Efarindodekin alfa, an investigational, masked IL-12, that is in Phase 2 clinical trial for patients with advanced solid tumors; and Vilastobart, an investigational tumor-activated, Fc-enhanced, high affinity binding anti-CTLA-4 monoclonal antibody. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.
OrganisationXilio Therapeutics
Headquarters828 Winter Street, Waltham, MA, United States, 02451
IndustryBiotechnology
CEODr. Rene Russo BCPS, Pharm.D.
E-voting on sharesClick here to vote

Key Management of Xilio Therapeutics

Name

Title

Mr. Nathan McBride

Chief Information Officer

Mr. Benjamin S. Harshbarger J.D.

Chief Legal Officer

Dr. Scott Coleman Ph.D.

Chief Development Officer

Ms. Ruth du Moulin

Senior Vice President of Medical Affairs

Dr. Rene Russo BCPS, Pharm.D.

President, CEO & Director

Mr. Christopher Frankenfield

CFO & COO

Mr. Kevin M. Brennan

Senior Vice President of Finance & Accounting

Dr. Uli Bialucha Ph.D.

Chief Scientific Officer

FAQs

What is Xilio Therapeutics share price today?

Xilio Therapeutics share price today is $9.46 as on at the close of the market. Xilio Therapeutics share today touched a day high of $9.75 and a low of $9.07.

What is the 52 week high and 52 week low for Xilio Therapeutics share?

Xilio Therapeutics share touched a 52 week high of $12.74 on and a 52 week low of $6.47 on . Xilio Therapeutics stock price today i.e. is closed at $9.46,which is 25.74% down from its 52 week high and 46.32% up from its 52 week low.

What is Xilio Therapeutics's market capitalisation today?

Xilio Therapeutics market capitalisation is $0.00T as on .

How to invest in Xilio Therapeutics Stock (XLO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Xilio Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xilio Therapeutics Shares that will get you 0.1586 shares as per Xilio Therapeutics share price of $9.46 per share as on August 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Xilio Therapeutics Stock (XLO) from India?

Indian investors can start investing in Xilio Therapeutics (XLO) shares with as little as ₹95.592 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.92 in Xilio Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Xilio Therapeutics share’s latest price of $9.46 as on August 18, 2026 at 1:29 am IST, you will get 1.0571 shares of Xilio Therapeutics. Learn more about fractional shares .